|
|
Found results for
 patents
1.
|
Molecular adjuvant and vaccine
| Application Number |
16745268 |
| Grant Number |
11179462 |
| Status |
In Force |
| Filing Date |
2020-01-16 |
| First Publication Date |
2020-11-19 |
| Grant Date |
2021-11-23 |
| Owner |
- CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (Spain)
- CZ VETERINARIA S.A. (Spain)
|
| Inventor |
- Alcolea Alcolea, Pedro José
- Alonso Ayala, Ana María
- Larraga Rodríguez De Vera, Vicente Emilio
|
Abstract
The invention relates to the fields of vaccines and vaccine adjuvants, and generally relates to polynucleotide adjuvants, polynucleotide vaccines and vaccine compositions. More specifically, the invention relates to said polynucleotides and vaccine compositions for use in inducing or enhancing a prophylactic or therapeutic immune response in a mammalian subject. Furthermore, it relates to said polynucleotides and vaccine compositions for use in the prophylactic or therapeutic treatment of an infectious disease, such as in the prophylactic or therapeutic treatment of leishmaniasis.
IPC Classes ?
- A61K 39/39 - Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A61P 33/02 - Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61K 39/008 - Leishmania antigens
- A61K 39/00 - Medicinal preparations containing antigens or antibodies
|
2.
|
MOLECULAR ADJUVANT AND VACCINE
| Application Number |
EP2016061621 |
| Publication Number |
2016/188973 |
| Status |
In Force |
| Filing Date |
2016-05-23 |
| Publication Date |
2016-12-01 |
| Owner |
- CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (Spain)
- CZ VETERINARIA, S.A. (Spain)
|
| Inventor |
- Alcolea Alcolea, Pedro José
- Alonso Ayala, Ana María
- Larraga Rodríguez De Vera, Vicente Emilio
|
Abstract
The invention relates to the fields of vaccines and vaccine adjuvants, and generally relates to polynucleotide adjuvants, polynucleotide vaccines and vaccine compositions. More specifically, the invention relates to said polynucleotides and vaccine compositions for use in inducing or enhancing a prophylactic or therapeutic immune response in a mammalian subject. Furthermore, it relates to said polynucleotides and vaccine compositions for use in the prophylactic or therapeutic treatment of an infectious disease, such as in the prophylactic or therapeutic treatment of leishmaniasis.
IPC Classes ?
- A61K 39/39 - Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A61K 39/008 - Leishmania antigens
|
|
